WOBURN, Mass., March 14, 2025 /PRNewswire/ — Azurity Pharmaceuticals (“Azurity”) announced today the successful completion of its acquisition of Covis Group S.Ã r.l. (“Covis”) from existing investors. With this acquisition, Covis is now a wholly-owned subsidiary of Azurity. This…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.